Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders
US9550756B2 · kind B2 · utility
1Cited by
11References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 17, 2014 |
| Grant date | Jan 24, 2017 |
| Priority date | — |
| Expiry date | Oct 17, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2059
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound which has the effect of PDE inhibition, and which is useful as a medicament for preventing or treating schizophrenia or so on.A compound of formula (I0):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.